Liver cancer growth tied to tryptophan intake

byUTSouthwestern Medical CenterSummary of our findings on Trp dependency and vulnerability in MYC-driven tumors. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-478

Updated on: August 27,2024

Liver cancer growth tied to tryptophan intake

byUTSouthwestern Medical CenterSummary of our findings on Trp dependency and vulnerability in MYC-driven tumors. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-478

Updated on:August 27,2024

Scientists find butyrate's possible anticancer potential is cell-type specific

FEBRUARY 27, 2024by Maribel Alonso,Agricultural Research ServiceDistinct effects of butyrate on colon cancer cell lines (A) HCT116, (B) HT-29, (C) Caco-2 cell growth curves for 24, 48, and 72 h,

Updated on: March 15,2024

Scientists find butyrate's possible anticancer potential is cell-type specific

FEBRUARY 27, 2024by Maribel Alonso,Agricultural Research ServiceDistinct effects of butyrate on colon cancer cell lines (A) HCT116, (B) HT-29, (C) Caco-2 cell growth curves for 24, 48, and 72 h,

Updated on:March 15,2024

Neoantigen DNA Vaccines: A Promising Approach for Triple Negative Breast Cancer

Among innovative strategies, neoantigen DNA vaccines have emerged as a particularly promising approach, offering hope for improved patient outcomes.

Updated on: November 15,2024

Neoantigen DNA Vaccines: A Promising Approach for Triple Negative Breast Cancer

Among innovative strategies, neoantigen DNA vaccines have emerged as a particularly promising approach, offering hope for improved patient outcomes.

Updated on:November 15,2024

Researchers link ovarian cancer to bacteria colonization in microbiome

by Susan Murphy,Mayo Clinicβ-diversities measures were compared. For β-diversity, Bray–Curtis (BC), unweighted, and weighted, UniFrac distance metrics were reported. The most significant metric

Updated on: February 20,2024

Researchers link ovarian cancer to bacteria colonization in microbiome

by Susan Murphy,Mayo Clinicβ-diversities measures were compared. For β-diversity, Bray–Curtis (BC), unweighted, and weighted, UniFrac distance metrics were reported. The most significant metric

Updated on:February 20,2024

Review paper compares two leading pancreatic cancer drugs

by Tyrel Linkhorn,University of ToledoPotential biomarkers in nab-paclitaxel/gemcitabine (a), Folfirinox (b) regimens of drug metabolism and mechanism of action. (c) Macrophages induce gemcitabi

Updated on: May 07,2024

Review paper compares two leading pancreatic cancer drugs

by Tyrel Linkhorn,University of ToledoPotential biomarkers in nab-paclitaxel/gemcitabine (a), Folfirinox (b) regimens of drug metabolism and mechanism of action. (c) Macrophages induce gemcitabi

Updated on:May 07,2024

In a clinical trial, blood thinners added to clot-busting medication did not improve stroke outcomes

by American Heart AssociationCredit: CC0 Public DomainGiving blood thinners in addition to clot-busting medications to people with ischemic strokes (clot-caused strokes) did not improve their out

Updated on: May 06,2024

In a clinical trial, blood thinners added to clot-busting medication did not improve stroke outcomes

by American Heart AssociationCredit: CC0 Public DomainGiving blood thinners in addition to clot-busting medications to people with ischemic strokes (clot-caused strokes) did not improve their out

Updated on:May 06,2024

Researchers discover possible new treatment for triple-negative breast cancer

by The Wistar InstituteDr. Zachary Schug, assistant professor at The Wistar Institute. Credit: The Wistar InstituteZachary Schug, Ph.D., assistant professor in the Molecular and Cellular Oncogene

Updated on: June 22,2024

Researchers discover possible new treatment for triple-negative breast cancer

by The Wistar InstituteDr. Zachary Schug, assistant professor at The Wistar Institute. Credit: The Wistar InstituteZachary Schug, Ph.D., assistant professor in the Molecular and Cellular Oncogene

Updated on:June 22,2024

Distinct signaling pathway identified as key driver for epithelial cancer development

by Kurt Bodenmüller,University of ZurichSide section of the skin with epidermal stem cells (green) with one particular clone in red. Cell nuclei are stained in blue, the white dashed lines indic

Updated on: August 03,2024

Distinct signaling pathway identified as key driver for epithelial cancer development

by Kurt Bodenmüller,University of ZurichSide section of the skin with epidermal stem cells (green) with one particular clone in red. Cell nuclei are stained in blue, the white dashed lines indic

Updated on:August 03,2024

Researchers reveal key to targeting dormant cancer cells

by Garvan Institute of Medical Research3D view of a growing cancer colony and a single dormant cancer cell attached to the inner lining of bone. Credit: Dr Michelle McDonaldAn international team

Updated on: June 11,2024

Researchers reveal key to targeting dormant cancer cells

by Garvan Institute of Medical Research3D view of a growing cancer colony and a single dormant cancer cell attached to the inner lining of bone. Credit: Dr Michelle McDonaldAn international team

Updated on:June 11,2024

New study generates predictive model to help identify melanoma patients best eligible for sentinel lymph node biopsy

by Sutter HealthDiscriminating Among Sentinel Lymph Node Biopsy Outcomes Using Various Prognostic Methodologies Receiver operating characteristic curve plots of sentinel lymph node biopsy outcome disc

Updated on: January 12,2024

New study generates predictive model to help identify melanoma patients best eligible for sentinel lymph node biopsy

by Sutter HealthDiscriminating Among Sentinel Lymph Node Biopsy Outcomes Using Various Prognostic Methodologies Receiver operating characteristic curve plots of sentinel lymph node biopsy outcome disc

Updated on:January 12,2024

Engineered peptides open new avenue for immunotherapy drug development

by University of Texas M. D. Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainIn a new study published in Nature Biomedical Engineering, researchers at The University of Texas MD Anderson Cance

Updated on: May 14,2024

Engineered peptides open new avenue for immunotherapy drug development

by University of Texas M. D. Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainIn a new study published in Nature Biomedical Engineering, researchers at The University of Texas MD Anderson Cance

Updated on:May 14,2024

Physicians IDs barriers to 'no antibiotic' strategy for pediatric viral pneumonia

by Elana GotkineThere are considerable barriers relating to implementation of a "no antibiotic" strategy for mild community-acquired pneumonia (CAP) in children, according to a study publish

Updated on: May 07,2024

Physicians IDs barriers to 'no antibiotic' strategy for pediatric viral pneumonia

by Elana GotkineThere are considerable barriers relating to implementation of a "no antibiotic" strategy for mild community-acquired pneumonia (CAP) in children, according to a study publish

Updated on:May 07,2024